2,4-Pyrrolidinedione,3-[(2E,4S,6R,8R,9R,10S,11R,12R,13R,14S,15R,17S,18S,19R,20S,21R,23R,25S,27S,28S,29R,30R,31S)-1,8,9,11,13,15,17,19,21,23,25,27,28,29,30,31-hexadecahydroxy-2,4,6,10,12,14,18,20-octamethyl-32-[(2R,3S,4S,5S,6S)-tetrahydro-3,4,5,6-tetrahydroxy-6-[(2R)-2-hydroxyundecyl]-2H-pyran-2-yl]-2-dotriaconten-1-ylidene]-1,5-dimethyl-,(3Z,5R)-,179729-59-0 Products Supply

Name: 2,4-Pyrrolidinedione,3-[(2E,4S,6R,8R,9R,10S,11R,12R,13R,14S,15R,17S,18S,19R,20S,21R,23R,25S,27S,28S,29R,30R,31S)-1,8,9,11,13,15,17,19,21,23,25,27,28,29,30,31-hexadecahydroxy-2,4,6,10,12,14,18,20-octamethyl-32-[(2R,3S,4S,5S,6S)-tetrahydro-3,4,5,6-tetrahydroxy-6-[(2R)-2-hydroxyundecyl]-2H-pyran-2-yl]-2-dotriaconten-1-ylidene]-1,5-dimethyl-,(3Z,5R)-
CAS NO.: 179729-59-0
Synonyms:
2,4-Pyrrolidinedione,3-[(2E,4S,6R,8R,9R,10S,11R,12R,13R,14S,15R,17S,18S,19R,20S,21R,23R,25S,27S,28S,29R,30R,31S)-1,8,9,11,13,15,17,19,21,23,25,27,28,29,30,31-hexadecahydroxy-2,4,6,10,12,14,18,20-octamethyl-32-[(2R,3S,4S,5S,6S)-tetrahydro-3,4,5,6-tetrahydroxy-6-[(2R)-2-hydroxyundecyl]-2H-pyran-2-yl]-2-dotriacontenylidene]-1,5-dimethyl-,(3Z,5R)- (9CI); Aflastatin A; N-Methylaflastatin B
Molecular Structure:
Molecular Formula: C62H115 N O24

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 2,4-Pyrrolidinedione,3-[(2E,4S; 2,4-Pyrrolidinedione,1-methyl-; 1/C33H42O7/c1-19-25-17-24-18-2; 1/C27H27N3O3S/c1-30-25(20-11-1; 1/C51H74N2/c1-5-9-13-17-21-49(; 1/C28H41N5O15S.Na/c1-12(2)21(2; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C22H28O6/c1-23-17-11-21(27-5; 4,10,14,29,30-Pentaoxa-32-azap; 1/C21H26N2O4/c1-3-14-8-9-19(25; 1/C19H15ClN2O2S/c1-11-19(23)24; 4,10,14,29,30-Pentaoxa-32-azap; 1/C30H52/c1-10-25(6)16-12-20-3; 8,12,45,46,47,48,50-Heptaoxahe; 1/C23H22N2O2/c26-23(27-22-15-2; (2R,3S,4S,6S)-3-{[(2S,4S,5R,6R; Propanoic acid,2-methoxy-,(1R,; Propanoic acid,2,3-dimethoxy-,; 1/C18H19NO4/c1-22-15-8-11-10(7; 1/C18H18O6/c1-22-14-8-13(20)15; 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C19H24N2O2/c1-12(2)14-8-6-9-; (3R,4S,5S,6R,7R,9R,11R,12R,13R; 6-Oxa-13,26-dithia-3,10,17,20,; [(2S,3S,4R,6S)-6-[(2R,3S,4S,5R; 1/C17H16N2O3/c1-9(20)12-8-14-1; 8,12,45,46,47,48,50-Heptaoxahe; 1/C16H15FN2O3S/c1-23(21,22)19-; 1/C20H20N2/c1-4-10-16(11-5-1)1; 1/C16H14ClNO3/c1-10-6-12(17)7-;